Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Titel:
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Auteur:
von Minckwitz, Gunter Schneeweiss, Andreas Loibl, Sibylle Salat, Christoph Denkert, Carsten Rezai, Mahdi Blohmer, Jens U Jackisch, Christian Paepke, Stefan Gerber, Bernd Zahm, Dirk M Kümmel, Sherko Eidtmann, Holger Klare, Peter Huober, Jens Costa, Serban Tesch, Hans Hanusch, Claus Hilfrich, Jörn Khandan, Fariba Fasching, Peter A Sinn, Bruno V Engels, Knut Mehta, Keyur Nekljudova, Valentina Untch, Michael